Clinical efficacy of complement C5a inhibition by IFX‐1 in hidradenitis suppurativa: an open‐label single‐arm trial in patients not eligible for adalimumab

Evangelos J. Giamarellos‐Bourboulis, M. Argyropoulou, Theodora Kanni, Themistoklis Spyridopoulos, Isabella Otto, O. Zenker, Ruipeng Guo, Niels C. Riedemann